Study on the optimal choice of therapeutic approaches for elderly women with advanced epithelial ovarian cancer

臧荣余,李子庭,汤洁,张志毅,蔡树模

DOI: https://doi.org/10.3760/j:issn:0254-9026.2003.09.006

2003-01-01

Abstract:Objective To investigate the role of cytoreductive surgery and chemotherapy for elderly Chinese women with advanced epithelial ovarian cancer (AEOC). Methods Twenty-eight patients diagnosed as AEOC at the age ≥ 70 years from 1986 to 1997 were retrospectively reviewed, with other 320 women with AEOC at the age70 years at the same period as control. Survival was calculated by Kaplan-Meier method with difference in survival estimated by Log-rank test. Independent prognostic factors were identified by the COX's stepwise regression model, and variants associated with disease recurrence were found by Logistic stepwise regression methods. Results The median age was 74 (ranged 70-82) years. There was no significant statistical difference in survival between elderly and non-elderly AEOC women with the median survival time of 17 and 24 months; 3-year survival of 26.7% and 35.7%; 5-year survival of 26.7% and 17.7%, respectively ( P 0.05). When elderly AEOC patients with residual cancer ≤ 1cm in size after surgical cytoreduction were compared to those with 1cm, there was a significant statistical difference in median survival of 61 and 12 months, respectively (χ 2 =16.60, P =0.0001). The median survival for patients with and without peritoneal chemotherapy were 27 and 12 months, respectively (χ 2 =3.45, P =0.0633). Residual disease, FIGO stage, recurrent ascites, uterus muscle involvement were independent prognostic determinants of survival identified by Cox's stepwise regression analysis. Conclusions Aggressive surgical cytoreduction should be performed in elderly AEOC patients as well as in younger patients, but multi-course platinum-based chemotherapy should be used in accordance with the performance status of elder women.